View Older Stories View More Recent Stories
-
Miravo Healthcare™ Enters into Definitive Agreement to be Acquired by Searchlight Pharma Inc.
-
Lumos Pharma, Inc. (LUMO) Announces KOL Review of Interim Phase 2 Data Supports Potential for New Oral Therapeutic Paradigm for Moderate Idiopathic PGHD Patients
-
KOL Review of Lumos Pharma’s Interim Phase 2 Data Supports Potential for New Oral Therapeutic Paradigm for Moderate Idiopathic PGHD Patients
-
KOL Review of Lumos Pharma’s Interim Phase 2 Data Supports Potential for New Oral Therapeutic Paradigm for Moderate Idiopathic PGHD Patients
-
Endologix Receives FDA Approval of PMA Supplement for AFX2 System
-
Healthcare and Life sciences Convener, Cure®, to Host Fireside Chat with Pulitzer Prize-Winner and New York Times Bestselling Author, Siddhartha Mukherjee
-
Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD
-
Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD
-
Deerfield Management Announces Third Annual XSeed Award to Support Underfunded and Underrepresented NYC Life Science Startups
-
Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference
-
Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference
-
Form 4 CareMax, Inc. For: Nov 17 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers
-
Quartet Launches Behavioral Health Care Clinic for Patients with Moderate to Severe Mental Illness
-
Adela's Co-Founder & Chief Scientific Officer to Deliver Plenary Session at American Association for Cancer Research (AACR) Special Conference on Precision Prevention, Early Detection, and Interce
-
Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
-
Miravo Healthcare™ Announces Third Quarter 2022 Results
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma (LUMO) Reports Encouraging Interim Results from Two Phase 2 Trials of Oral LUM-201
-
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
-
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
-
Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
-
The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
-
The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
-
Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors
-
ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
-
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
-
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
-
Form SC 13D/A CareMax, Inc. Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Rain Therapeutics (RAIN) Prices 6.86M Share Offering at $5.83/sh
-
Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
-
Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference
-
Abeona Therapeutics (ABEO) Prices 7.6M Share Private Placement at $4.6/sh
-
Abeona Therapeutics Announces $35 Million Private Placement Financing
-
Abeona Therapeutics Announces $35 Million Private Placement Financing
-
Deerfield Management and BioSymetrics partner to discover and develop novel therapeutics
-
Element Science Appoints Trish Howell as Chief Operating Officer
-
Adaptive Phage Therapeutics Appoints Edward Fang as Chief Medical Officer
-
Cosylab and Deerfield Management seek to increase awareness around designing, financing, and operating a Boron Neutron Capture Therapy (BNCT) center
-
COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation
-
ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTO® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium
-
QUARTET HEALTH ADDS FIVE INDUSTRY LEADERS TO ITS GROWING EXECUTIVE TEAM
-
Advancium Health Network, Launched by Deerfield Management, Receives $30M from Maxine and Stuart Frankel Foundation
-
Sientra (SIEN) Reports Prelim. Q3 Revenue About In-Line with Consensus
-
Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management
-
Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital
-
Dracen Pharmaceuticals announces publication in Molecular Cancer Therapeutics
-
Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOURTM System.
